who discovered glp-1 agonists Evolution of GLP‐1 Receptor for Diabetes Treatment GLP-1 Agonists: Semaglutide & Liraglutide

In a clinical study of 205 participants, those taking Novo Nordisks pill for 64 weeks lost an average of 16.6% of their body weight among participants who remained on treatment

Our observations about the efficacy of GLP-1 RAs in enhancing survival and reducing cardiovascular events are concordance with evidence from several cardiovascular outcome trials (CVOTs) conducted in general population with T2DM, as well as a recent cohort study focused on solid organ transplant recipients [16,17,18,19, 23]

doi: 10.3390/genes10100798 [DOI] [PMC free article] [PubMed] [Google Scholar] 49

Recent findings from the SUSTAIN-7 study demonstrated semaglutide's superiority over dulaglutide in enhancing glycaemic management and facilitating significant weight reduction, while preserving similar safety profiles (Pratley et al

Slows Gastric Emptying: GLP-1 slows down the rate at which food leaves the stomach

Key Ingredients That Support GLP-1 Function GLP-1 Patch Benefits for Overall Wellness Supporting your body's natural GLP-1 production is about fostering a greater sense of well-being, not pursuing a specific outcome such as weight loss